MAETZOLD DEREK J bought CSTL
June 15, 2026 · Form 4 insider transaction
MAETZOLD DEREK J bought 550 shares of Castle Biosciences, Inc. at $2.39 per share, a transaction worth $1.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
550
Price
$2.39
Total value
$1.3K
InsiderMAETZOLD DEREK J
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 15, 2026
Filing dateJune 17, 2026
Shares owned after22,029
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 3, 2025.